InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Ravina Bernard, Directeur Médical. Officer active across 1 company, notably Praxis Precision Medicines, Inc.. Cumulatively, 2 reports have been recorded. History available since 7 January 2022. The latest transaction was disclosed on 12 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ravina Bernard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
3,057 股@ US$12.85100.0% 占其流量Common StockSEC:0001689548-22-000007:0
22,000 股0Common StockSEC:0001104659-22-003162:0
2 条申报中的 2 条
About Ravina Bernard
Bernard Ravina is Chief Medical Officer at Praxis Precision Medicines, Inc. In this role, he is responsible for the medical direction and clinical development strategy of the company. His expertise in medicine and clinical research is essential for the development of new treatments.
